Gilead Sciences (GILD) | AbbVie (ABBV) | What Hep C Patients & Investors Need To Know!

Gilead Sciences, Inc. (NASDAQ: GILD) If you’re a Gilead Sciences follower, patient, or investor, you know what they do. The company is currently the leader in the treatment of hepatitis C. The company’s treatments Harvoni and Sovaldi have incredibly high cure rates, low side effects, and the patient needs to take less medication overall than … Read more